Effect of Red Cell Distribution Width on Long-term Follow-up Study in Patients With Acute Pulmonary Thromboembolism
10.3969/j.issn.1000-3614.2016.01.014
- VernacularTitle:红细胞分布宽度在急性肺血栓栓塞症患者长期随访中的作用
- Author:
Qunying XI
;
Yong WANG
;
Zhihong LIU
;
Zhihui ZHAO
;
Qin LUO
;
Qing GU
;
Changming XIONG
;
Xinhai NI
- Publication Type:Journal Article
- Keywords:
Pulmonary embolism;
Hypertension,pulmonary;
Red blood cell distribution width
- From:
Chinese Circulation Journal
2016;31(1):65-68
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the effect of red blood cell distribution width (RDW) on long-term follow-up study in patients with acute pulmonary thromboembolism (APE).
Methods:A total of 214 consecutive patients with the first episode of APE admitted in our hospital from 2009-01 to 2012-12 were enrolled. The patients were divided into 2 groups:RDW≤15%group, n=202 and RDW>15%group, n=12. Baseline RDW was measured at admission, the follow-up study was conducted at 3, 6, 12 months thereafter, and then at once per year. The major primary end point was chronic thromboembolic pulmonary hypertension (CTEPH). The independent predictor for CTEPH occurrence was studied by uni-and multivariate logistic regression analysis and the predictive capability of RDWwas evaluated by ROC curve.
Results: All patients ifnished the follow-up study at the mean of (31±17) months. The overall occurrence rate of CTEPH was 7.5% (16/214), which was higher in RDW>15% group than that in RDW≤15% group (33.3% vs 5.9%, P=0.002). Multivariate logistic regression analysis indicated that with adjusted clinical data and other predictors, RDW>15%was still the strong predictor for CTEPH occurrence (OR=7.916, 95%CI 1.474-42.500, P=0.016). Adding RDW to the evaluating model, the predictive capability could be signiifcantly improved by ROC curve (AUC increased from 0.856 to 0.901, P<0.01).
Conclusion: Elevated RDW is the independent predictor for CTEPH occurrence in APE patients, which is helpful to estimate the prognosis and treatment strategy in APE patients.
